Passage Bio, Inc. PASG
Set alert
3.45 USD -0.07 -1.99%
At close · Oct 30
3.45 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
3.45 Day range 3.61
3.33 52-week range 19.85
- YTD
- -70.76%
- 1 year
- -53.38%
- Open
- 3.61
- Prev close
- 3.52
- Mkt cap
- 11.10M
- Vol
- 7.17K
- Avg vol
- 19.75K
- EPS
- -11.33
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 3.45
- High
- 3.61
- Forward P/E
- -1.30
- Beta
- 1.20
- Short ratio
- 6.61
- Inst. own
- 59.68%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 8, 2024
- 50-d avg
- 0.6579
- 200-d avg
- 0.93243
- 1y target
- 8.00
Financial health
Altman Z-Score
-43.90 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 2
Valuation
P/E -0.8×
FY 2018 5y median -0.6× FY 2025
P/S 0.0×
FY 2018 5y median 0.0× FY 2025
P/B 2.0×
FY 2018 5y median 0.6× FY 2025
P/FCF -1.2×
FY 2018 5y median -0.7× FY 2025
EV/EBITDA -0.3×
FY 2018 5y median -0.5× FY 2025
EV/Sales 0.0×
FY 2018 5y median 0.0× FY 2025
FCF Yield -84.2%
FY 2018 5y median -140.1% FY 2025
Profitability
Gross Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2018 5y median 0.0% FY 2025
ROE -242.7%
FY 2018 5y median -91.7% FY 2025
ROIC -100.9%
FY 2018 5y median -72.8% FY 2025
ROA -73.1%
FY 2018 5y median -63.2% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2018 FY 2025
Operating Income 38.7%
FY 2018 FY 2025
EPS (diluted) 33.1%
FY 2018 FY 2025
Free Cash Flow 34.3%
FY 2018 FY 2025
Financial Health
Current Ratio 2.1×
FY 2018 5y median 7.2× FY 2025
Quick Ratio 2.1×
FY 2018 5y median 7.2× FY 2025
Debt / Equity 1.3×
FY 2018 5y median 0.2× FY 2025
Net Debt / EBITDA 0.5×
FY 2018 5y median 0.2× FY 2025
Interest Coverage 0.0×
FY 2018 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31